
CAS 656247-18-6
:Nintedanib esylate
Description:
Nintedanib esylate is a small molecule tyrosine kinase inhibitor primarily used in the treatment of certain types of cancer, particularly non-small cell lung cancer and idiopathic pulmonary fibrosis. It functions by inhibiting multiple receptor tyrosine kinases involved in tumor growth and angiogenesis, including VEGFR, PDGFR, and FGFR. The compound is characterized by its complex chemical structure, which includes a bicyclic core and various functional groups that contribute to its pharmacological activity. Nintedanib esylate is typically administered orally and is known for its moderate to high bioavailability. It is also associated with a range of side effects, including gastrointestinal disturbances and liver enzyme elevations. The substance is soluble in organic solvents and exhibits stability under standard storage conditions. Its development has been guided by extensive clinical trials, demonstrating its efficacy in slowing disease progression in targeted patient populations. As with any pharmaceutical agent, its use should be closely monitored by healthcare professionals to manage potential adverse effects and interactions with other medications.
Formula:C31H33N5O4·C2H6O3S
InChI:InChI=1S/C31H33N5O4.C2H6O3S/c1-34-15-17-36(18-16-34)20-27(37)35(2)24-12-10-23(11-13-24)32-29(21-7-5-4-6-8-21)28-25-14-9-22(31(39)40-3)19-26(25)33-30(28)38;1-2-6(3,4)5/h4-14,19,32H,15-18,20H2,1-3H3,(H,33,38);2H2,1H3,(H,3,4,5)/b29-28-;
InChI key:InChIKey=MMMVNAGRWOJNMW-FJBFXRHMSA-N
SMILES:C(\NC1=CC=C(N(C(CN2CCN(C)CC2)=O)C)C=C1)(=C\3/C=4C(NC3=O)=CC(C(OC)=O)=CC4)/C5=CC=CC=C5.S(CC)(=O)(=O)O
Synonyms:- (3Z)-2,3-Dihydro-3-[[[4-[Methyl[2-(4-Methyl-1-piperazinyl)acetyl]aMino]phenyl]aMino]phenylMethylene]-2-oxo-1H-indole-6-carboxylic acid Methyl ester ethanesulfonate
- 1H-Indole-6-carboxylic acid, 2,3-dihydro-3-[[[4-[methyl[(4-methyl-1-piperazinyl)acetyl]amino]phenyl]amino]phenylmethylene]-2-oxo-, methyl ester, (3Z)-, monoethanesulfonate
- 1H-Indole-6-carboxylic acid, 2,3-dihydro-3-[[[4-[methyl[2-(4-methyl-1-piperazinyl)acetyl]amino]phenyl]amino]phenylmethylene]-2-oxo-, methyl ester, (3Z)-, ethanesulfonate (1:1)
- Nintedanib Esylate
- Nintedanib ethanesulfonate
- Ofev
- Nintedanib esylate. Nintedanib ethanesulfonate salt
- Nintedanib ethanesulfonate salt
- BIBF1120 ethanesulfonate salt
- Nintedanib
- Nintedanib Ethanesulfonate (Intedanib Ethanesulfonate)
- Nintedanib(ethanesulfonic acid)
- Brand name OFEV. Vargatef.
- BIBF 1120 BIBF-1120
- Nintedani
- Trinidad Neeb esylate
- Trinidad Neeb ethanesulfonate
- BIBF1120; BIBF 1120 BIBF-1120; NINTEDANIB ESYLATE. NINTEDANIB ETHANESULFONATE SALT; INTEDANIB; BRAND NAME OFEV. VARGATEF.
- BIBF-1120 esylate
- BIBF 1120 esylate
- (Z)-Methyl 3-(((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylene
- Intedanib ethanesulfonate
- BIBF1120/nintedanib ethanesulfonate salt
- (Z)-methyl 3-(((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate ethanesulfonate
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 9 products.
(3Z)-2,3-Dihydro-3-[[[4-[methyl[2-(4-methyl-1-piperazinyl)acetyl]amino]phenyl]amino]phenylmethylene]-2-oxo-1h-indole-6-carboxylic acid methyl ester ethanesulfonate
CAS:Formula:C33H39N5O7SPurity:98%Color and Shape:SolidMolecular weight:649.7571Ref: IN-DA0039OF
1g77.00€5g164.00€10g255.00€25g649.00€50gTo inquire100gTo inquire250gTo inquire500gTo inquire100mg36.00€250mg52.00€Nintedanib Esilate
CAS:Controlled ProductFormula:C31H33N5O4·C2H6O3SColor and Shape:NeatMolecular weight:649.76Nintedanib esylate
CAS:<p>Nintedanib esylate (BIBF 1120 esylate) is a potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1/2/3 and PDGFRα/β</p>Formula:C31H33N5O4·C2H6O3SPurity:99.43% - 99.96%Color and Shape:SolidMolecular weight:649.76Nintedanib ethanesulfonate
CAS:<p>Used for treatment of idiopathic pulmonary fibrosis</p>Formula:C31H33N5O4•C2H6O3SPurity:Min. 98 Area-%Color and Shape:PowderMolecular weight:649.76 g/mol







